Likely active: new deal Oct 2025 Verified 7 Nov 2026
V-Bio Ventures
Belgian life science venture capital firm that co-creates and invests in early- to mid-stage therapeutics companies in Europe, with a preferred relationship with the VIB research institute.
- Type
- VC firm
- Location
- Belgium
- Stages
- Seed, Series A, Series B
- Sectors
- Healthtech and life sciences, Biotech
- Fund size / AUM
- EUR 186M across 2 funds (own site)
- Website
- www.v-bio.ventures
Contacts on file
For V-Bio Ventures, the paid file holds: 5 named decision-makers with roles; firm contact email (domain checked).
Get Europe Complete, $99 Free sample
One-time payment. No subscription. No account.
Notable investments
Muna TherapeuticsConfo TherapeuticsTanai TherapeuticsFlindr Therapeutics
Sources
- www.v-bio.ventures/
- www.v-bio.ventures/news/
- registers.esma.europa.eu/publication/searchRegister?core=esma_registers_funds
Last checked 7 Nov 2026. Is something wrong? Tell us.
Appears in 18 lists
Series B biotech investors (73)Biotech investors in Europe (89)Series B investors in Europe (117)Series A biotech investors (153)Series B healthtech investors (160)Healthtech investors in Europe (291)Seed biotech investors (300)Series A investors in Europe (329)Series B investors (339)Series A healthtech investors (401)Venture capital firms in Europe (412)Biotech investors (484)Seed investors in Europe (543)Startup investors in Europe (725)Seed healthtech investors (800)Series A investors (864)Healthtech investors (1,207)Seed investors (1,892)